Next Article in Journal
Inhibitory Effect of Phosphorothioate Oligonucleotide Complementary to G6PD mRNA on Murine Melanoma
Next Article in Special Issue
Recombinant Soybean Lipoxygenase 2 (GmLOX2) Acts Primarily as a ω6(S)-Lipoxygenase
Previous Article in Journal
The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
Previous Article in Special Issue
The Potential of Stilbene Compounds to Inhibit Mpro Protease as a Natural Treatment Strategy for Coronavirus Disease-2019
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
CIMB
Volume 45
Issue 4
10.3390/cimb45040206
cimb-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Different Directions of Effects of Polyclonal IgG Antibodies from Patients with Schizophrenia and Healthy Individuals on Cell Death In Vitro: A Pilot Study

by
Elena V. Epimakhova
1,2,†,
Liudmila P. Smirnova
1,†,
Daria V. Kazantseva
1,
Daria A. Kamaeva
1 and
Svetlana A. Ivanova
1,3,*
1
Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Aleutskaya Str., 4, 634014 Tomsk, Russia
2
Division of Biology and Genetics, Siberian State Medical University, Moskovsky Trakt, 2, 634050 Tomsk, Russia
3
Department of Psychiatry, Addictology and Psychotherapy, Siberian State Medical University, Moskovsky Trakt, 2, 634050 Tomsk, Russia
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Curr. Issues Mol. Biol. 2023, 45(4), 3168-3179; https://doi.org/10.3390/cimb45040206
Submission received: 28 February 2023 / Revised: 29 March 2023 / Accepted: 2 April 2023 / Published: 6 April 2023
(This article belongs to the Special Issue New Sight: Enzymes as Targets for Drug Development)
Browse Figures
Versions Notes

Abstract

:
Numerous studies indicate the involvemen of oxidative stress in the pathogenesis of schizophrenia. It has been shown that the serum pool of antibodies in patients with schizophrenia contains catalytically active antibodies (abzymes) that have a wide range of activities, including redox properties. In the present work, the effects of IgGs—having oxidoreductase activities—isolated from the serum of patients with schizophrenia and healthy individuals were studied in vitro. The IgGs were purified by affinity chromatography followed by an SDS-PAGE analysis of homogeneity in a 4–18% gradient gel. The catalase and superoxide dismutase (SOD) activities of the IgGs were measured spectrophotometrically using a kinetic module. Human neuroblastoma SH-SY5Y cells were cultured with IgG at a final concentration of 0.2 mg/mL for 24 h. In a parallel experiment, tert-butyl hydroperoxide was used as an oxidative stressor. The number of dead cells after incubation was determined with fluorescent dyes, propidium iodide and Hoechst, by high-throughput screening on the CellInsight CX7 platform. A cytotoxic effect of the IgG from the schizophrenia patients on SH-SY5Y cells was detected after 24 h incubation. A correlation was found between the SOD activity of the IgGs and IgG-induced cell death. Under the induced oxidative stress, the cytotoxic effect of the IgG from the patients with schizophrenia on the SH-SY5Y cell line was five times stronger. Meanwhile, the IgG from the healthy individuals exerted a cytoprotective effect on the cultured cells, accompanied by high catalase activity. Thus, the observed influence on cell viability depends on the catalytic properties of the abzymes.

1. Introduction

In recent years, it was found that immunoglobulins of various classes have an ability to not only bind an antigen but also to catalyze chemical reactions with it [1]. Such antibodies are called abzymes. Catalytically active antibodies were discovered in autoimmune diseases (e.g., Hashimoto’s thyroiditis, systemic lupus erythematosus, and multiple sclerosis) and later were also found in inflammatory diseases and in healthy people [2,3,4]. The presence of catalytic properties in antibodies substantially increases their functional potential but at the same time can lead to pathological effects; however, the biological role of abzymes in the pathogenesis of diseases remains poorly understood. Recently, schizophrenia was postulated as one of the diseases whose pathogenesis is associated with inflammation. In patients with schizophrenia, numerous studies have proved changes in the concentration of cytokines in the peripheral blood and cerebrospinal fluid, an increase in the concentration of neurospecific autoantibodies, and the activation of microglia [5,6,7]. Meanwhile, the functions of serum antibodies with catalytic properties have been under active investigation in recent years. Oxidative stress is also an important factor for the initiation and progression of this disease, as evidenced by an imbalance in the antioxidant defense system in patients during the first episode and patients with chronic forms of schizophrenia receiving long-term antipsychotic treatment [8,9,10]. Disturbances of the redox balance in schizophrenia lead to alterations in various metabolic and signaling pathways, thereby eventually contributing to aberrant neuronal development, hypomyelination, immune system dysfunction, and the development of inflammatory processes [11,12,13]. According to the literature, schizophrenia is associated with the hyperproduction of the superoxide anion owing to the activity of NADPH-dependent oxidase [14]. It is also known that oral haloperidol increases the formation of the superoxide anion in the body [12]. In addition, in patients with schizophrenia, the SOD activity in plasma and polymorphonuclear leukocytes is significantly reduced but is significantly increased in serum as compared to healthy individuals [15]. Studies have also shown a link between schizophrenia and polymorphisms of manganese superoxide dismutase (Mn-SOD) synthesis genes: a comparative proteomic analysis of postmortem human hippocampal tissue samples revealed that the concentration of Mn-SOD is significantly diminished in the hippocampus of a schizophrenia patient [16].
IgG SOD activity has been found in schizophrenia and multiple sclerosis, but the function of abzymes having antioxidant activity is not fully understood. Over the past few years, abzymes with nuclease [17,18], proteolytic [19,20], catalase [21], and superoxide dismutase (SOD) activities [22] have been found in the blood serum of patients with schizophrenia. One hypothesis about the pathogenesis suggests that catalytic antibodies with catalase and SOD activities help protect the body from excessive concentrations of reactive oxygen species (ROS) [23,24]. On the other hand, there is a hypothesis that catalytic antibodies have cytotoxic properties (they affect intracellular processes and activate membrane damage and apoptosis), which are especially pronounced in autoimmune diseases. For example, in systemic lupus erythematosus, polyclonal DNA-hydrolyzing antibodies have been found that influence the viability of cell lines L929, HL-60, Raji, and K562 [25]. It has been demonstrated that the cytotoxicity of such antibodies is predicated, first, on their ability to penetrate the cell by endocytosis and to cause nuclear DNA fragmentation, which leads to caspase-dependent cell death. Second, cytotoxic antibodies can interact with cell surface receptors, triggering apoptosis. In this regard, an in vitro experiment concerning the impact of antibodies having oxidoreductase activities from schizophrenia patients on cell death in a neuroblastoma cell model will allow us to establish the protective or cytotoxic properties of such IgGs.

2. Materials and Methods

2.1. Description of Participants of the Study

The investigation of catalase and SOD activities belonging to antibodies was performed in 16 patients with schizophrenia (the male/female ratio was 62.0%/38.0%). All patients were recruited from the Department of Endogenous Disorders at the Mental Health Research Institute of TNMRC (Tomsk, Russia). The median age of the patients was 40.50 years [interquartile range: 38.00; 45.50] with a minimum of 20 years and a maximum of 60 years. The diagnosis of paranoid or simple schizophrenia was made in accordance with the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) and the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). The list of exclusion criteria was as follows: detection of an acute infectious, decompensated chronic disease or a site of inflammation; autoimmune or neurological pathologies; detection of organic or other mental disorders not included in the study; and mental retardation.
The control group was composed of 18 mentally and somatically healthy people (the male/female ratio was 39%/61%). The age of the participants in this group ranged from 21 to 65 years, and the median was 44.00 [35.00; 49.00] years. The exclusion criteria for the control group were the presence of an acute infectious, decompensated chronic disease or a site of inflammation, autoimmune or neurological pathologies, organic brain lesions, and the presence of mental disorders (Table 1).
The study protocol was designed according to the Helsinki ethics committee guidelines and was approved by the Local Bioethics Committee of the Mental Health Research Institute (protocol No. 157/1.2022). Written informed consent was obtained from each study participant before the study. Consent from next of kin was not required because the participants’ ability to give consent was not compromised.

2.2. Materials

Biomaterial preparation included blood sampling from the cubital vein into Vacutainer tubes (BD, Franklin Lakes, NJ, USA) containing a clot activator after an overnight fast. Blood samples were collected from the patients before the time of day when an antipsychotic drug was taken. Serum separation was performed by centrifugation at 2000× g and 4 °C for 20 min in a refrigerated centrifuge (Orto Alresa Digicen 21R; Madrid, Spain). Serum was aliquoted and stored at −80 °C until subsequent isolation of immunoglobulins.

2.3. Isolation of Serum Immunoglobulins on Protein G Sepharose

Immunoglobulins G were isolated from individual serum samples of schizophrenia patients and healthy controls by affinity chromatography on an ÄKTA Pure 25 chromatograph (GE Healthcare Bio-Sciences, Uppsala, Sweden). Serum after 3-fold dilution with Tris-buffered saline (TBS; 0.05 M Tris-HCl pH 7.5 and 0.15 M NaCl) was applied to a Protein G Sepharose column (HiTrap™ Protein G HP, GE Healthcare). After the sample loading, the column was washed to zero optical density at 280 nm (A280) with TBS. At the first step, the elution of lipids and nonspecifically adsorbed proteins was performed with TBS-Tween buffer (1% Triton X-100, 0.05 M Tris-HCl pH 7.5, and 0.3 M NaCl). IgGs were eluted with 0.1 M glycine-HCl buffer (pH 2.6). The eluate was fractionated and neutralized immediately with 1 M Tris-HCl buffer (pH 8.8). Between the stages of antibody purification, the columns were washed with TBS until A280 of the eluate reached zero [20]. Then, the homogeneity of IgGs was tested by SDS-PAGE analysis in a 4–18% gradient gel.

2.3.1. Dialysis of Purified Antibodies

To remove low-molecular-weight substances, the isolated IgG antibodies were dialyzed. Immediately before dialysis, the dialysis membranes were boiled for 10 min to promote pore opening. The fractions of eluted antibodies were dialyzed against 0.02 M sodium phosphate buffer (pH 7.0) at 4 °C on a magnetic stirrer for 17 h [23].

2.3.2. Protein Concentration Assessment

The IgG concentration was analyzed on a Varioskan LUX spectrophotometer (Thermo Scientific, Waltham, MA, USA) located at the core facility Medical Genomics at Tomsk National Research Center. IgG concentrations in the samples were calculated from a standard calibration curve for IgG.

2.4. Assessment of IgG’s Catalase Activity

IgG catalase activity was assessed by means of a decrease in absorbance caused by the degradation of hydrogen peroxide in accordance with ref. [26]. The reaction mixture consisted of 50 mM potassium phosphate (pH 7.0), 30 μM H2O2, and purified antibodies at 0.5 mg/mL. Spectrophotometric analysis was carried out at 240 nm within 5–8 min using a Cary 60 spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). For the subsequent activity calculations, we chose only data from the time intervals showing a linear dependence of relative enzymatic activity on IgG concentration. The molar extinction coefficient of hydrogen peroxide for the calculation of the activity was taken from [21]. Specific activity was expressed in µM H2O2/min/mg IgG.

2.5. Assessment of IgG’s SOD Activity

The assessment of IgG SOD activity was based on the inhibition of the reduction of nitroblue tetrazolium by superoxide radicals. Oxidation of xanthine to uric acid in the presence of xanthine oxidase leads to the formation of superoxide radicals, which in turn results in reduced diformazan derived from nitroblue tetrazolium. The difference in the amount of reduced diformazan between samples without IgG (a spontaneous reaction) and samples manifesting the inhibitory effect of IgG SOD activity (an induced reaction) at a wavelength of 560 nm was employed to evaluate the enzymatic activity.
SOD activity of IgG was expressed in the following units: the difference in optical density between the spontaneous and induced reaction proceeding for 1 min in terms of mg of IgG (µM diformazan/min/mg IgG) [22].

2.6. Assessment of Cell Viability

The influence of IgG samples on cell viability was evaluated on cultured human neuroblastoma SH-SY5Y cells. SH-SY5Y cells were cultured at 37 °C, 90% relative humidity, in a humidified atmosphere containing 5% of CO2 (in a CO2 incubator: Sanyo MCO-5AC, Japan) in the DMEM medium supplemented with 50 U/mL penicillin, 50 µg/mL streptomycin, and 10% of fetal bovine serum. This culture medium was refreshed every 2–3 days.
To investigate the effects of IgG on cell viability, SH-SY5Y cells were seeded in 96-well plates (104 cells per well), and a day later, IgG antibodies were added at a final concentration of 0.2 mg/mL, followed by culturing for 24 h. As a control culture, we utilized (1) SH-SY5Y cells grown in the aforementioned culture medium without the addition of IgG and (2) B culture, in which an equivalent volume of phosphate buffer pH 7.0 (the buffer for antibody dialysis) was added instead of IgG. The indicated concentrations of IgG antibodies was selected empirically in previous experiments [27].
To assess properties of the immunoglobulins under oxidative stress, tert-butyl hydroperoxide (TBH) was added to SH-SY5Y cells at a final concentration of 500 μM. SH-SY5Y cells were incubated with IgG as described above (0.2 mg/mL IgG for 24 h), and then TBH was added for 4 h incubation at the above concentration. The indicated concentration of TBH was chosen according to results of our own experiments [28].
Dead cells were counted on the CellInsight CX7 HCS platform (Thermo Fisher Scientific, USA) at the core facility Medical Genomics (Tomsk Scientific Research Center) by using fluorescent dyes Hoechst (stains all cell nuclei, signal registration at 386 nm) and propidium iodide (stains the nuclei of dead cells, signal registration at 560 nm). Nuclei were then identified and analyzed based on signal fluorescence intensity in HCS Studio™ cell analysis software (Thermo Fisher Scientific).

2.7. Statistics

Statistical analyses were performed in SPSS, version 23 (IBM Company, Westchester, NY, USA). The data were tested for the normality of the distribution by the Shapiro–Wilk test. Description statistics are shown as a median with 25% and 75% quartiles (Me [Q1; Q3]) or mean and standard deviation (m ± SD). Differences were considered statistically significant at p-values less than 0.05. Between-group differences were evaluated by Student’s t test for independent samples with a normal distribution.

3. Results

3.1. Application of Stringent Criteria to Define Oxidoreductase Activity as an Intrinsic Property of an Antibody

Stringent criteria were applied to define oxidoreductase activity as an intrinsic property of IgGs: the binding of antibodies to an IgG-affinity sorbent, the demonstration of the homogeneity of purified IgGs via electrophoresis in a polyacrylamide gel, and a match between the activity profile and the protein profile after gel filtration chromatography under acidic conditions (pH shock analysis). The list of these criteria includes the most convincing and widely applicable tests that have been used by independent research groups over the past 30 years. Below, we present the results of these experiments in more detail.
The specific interaction of the protein G Sepharose with the Fc fragment of IgG and the isolation of such fractions during affinity chromatography (followed by dialysis) allowed us to obtain IgG without contaminants.
The homogeneity of the 150 kDa IgG was confirmed by 4–18% SDS-PAGE (Figure 1).
The assays of the SOD and catalase activities of the IgGs from the blood serum showed that the activities remained after gel filtration under acid shock only in the fractions corresponding to the optical density profile of the antibodies and were not detectable in the other fractions.
Figure 2 presents an overlay of the absorbance profile of the eluted protein (IgG) and the levels of both the SOD and catalase activities for each individual fraction obtained during the gel filtration. The proof that the activity belongs to IgGs is the match between the SOD or catalase activity maximum and the top of the chromatographic peak corresponding to IgG.
Taken together, the results of the series of experiments clearly indicated that homogeneous individual polyclonal immunoglobulins with catalytic properties were obtained successfully.

3.2. Results of the Cell Experiment

The incubation of the SH-SY5Y cell line for 24 h with IgG isolated from the blood of the healthy individuals or the patients with schizophrenia was performed on the CellInsight CX7 HCS platform (Thermo Fisher Scientific, USA). For all the immunoglobulin samples, the catalase and SOD activities were determined beforehand.
We also conducted an experiment reproducing oxidative stress by adding a high concentration of TBH to the culture medium. The culture medium without this chemical served as a control. By means of the CellInsight CX7 HCS platform, the dead cells were counted at the end of the experiment.
The levels of the catalase and SOD activities of the IgG from the patients in the acute phase of schizophrenia and the healthy individuals are presented in Table 2. According to the results of the experiment, the catalase activity of the IgGs from the patients in the acute phase of schizophrenia is three times lower as compared to the healthy individuals (p = 0.02). The SOD activity of the IgGs from the patients was statistically significantly higher than that from the healthy people (p = 0.02; Table 2).
At the same time, between these two oxidoreductase activities, there was a significant strong negative correlation, r = −0.784, consistently with canonical functions of the enzymes in question: catalase and SOD.
The proportion of the dead cells among the SH-SY5Y cells after incubation with the IgG having a proven catalytic activity was calculated from the proportion of the nuclei stained with the fluorescent dye propidium iodide (stains the nuclei of the dead cells) among all the nuclei stained with Hoechst (Figure 3).
After the experiment, it turned out that the immunoglobulins G from the serum of the patients in the acute phase of schizophrenia had a significant cytotoxic effect on the SH-SY5Y cell line after 24 h of incubation. A statistically significant increase in the number of dead SH-SY5Y cells was found when the antibodies from the patients were added to the culture medium, in comparison with the antibodies from the healthy individuals (p = 0.038); in the comparison to the incubation without antibodies, this effect was even more pronounced (p = 0.0043). No influence of the serum IgG from the healthy people on cell death was detectable: the number of dead cells in this case did not differ from that in the control (culture medium alone; p = 0.33; Figure 4).
We also tested the impact of induced oxidative stress on cell survival under the above conditions. TBH was utilized as an inducer of cell death to model oxidative stress. Preincubation with TBH resulted in a fivefold increase in the percentage of dead cells. Next, after supplementation of the medium with IgG from the schizophrenia patients, the cytotoxic effect of TBH on the SH-SY5Y cell line was still present. Moreover, the cytotoxic effect of the coincubation of the cultured cells with TBH and IgG from the patients with schizophrenia was statistically significantly much more pronounced. The increase in the percentage of dead SH-SY5Y cells under the influence of antibodies from the patients with schizophrenia was highly significant in comparison with the culture medium alone (p = 0.00012), and the difference from the healthy donor control was even greater (p = 0.000003).
Moreover, a cytoprotective property was found in the IgG samples from the healthy individuals. The number of dead SH-SY5Y cells was significantly lower in comparison with the culture medium alone (p = 0.0123; Figure 5).
In addition, in the group of patients with schizophrenia, a significant moderate positive correlation was found between the percentage of dead cells and the SOD activity of the patients’ IgG samples (r = 0.439) as well as a significant weak correlation between the percentage of cells showing oxidative stress-induced death and the level of catalase activity (r = 0.355).

4. Discussion

In schizophrenia, there is evidence of immunological dysregulation [29,30] and the activation of humoral immunity [15], along with generalized oxidative stress [12] and a local decrease in the activity of antioxidant systems [31,32]. In this regard, the experimental findings presented in this work make a substantial contribution to the understanding of the mechanisms of action of abzymes possessing oxidoreductase properties in the human body and to explaining several components of schizophrenia pathogenesis associated with oxidative stress. Our SOD assay revealed that the activity of the serum IgG from the patients with schizophrenia is significantly higher as compared to healthy people, while the catalase activity in the same pool of immunoglobulins G is significantly lower relative to healthy individuals. These opposite changes in the two oxidoreductase activities were confirmed by a significant moderate negative correlation (r = −0.784).
In the next experiment, the aim was to examine the effect of IgGs having oxidoreductase activities from schizophrenia patients or healthy individuals on cell death. We assumed that the neuroblastoma cell line was the most suitable model for the first stage of our experimental study. Human neuroblastoma cell line SH-SY5Y is the most popular in vitro model in neuropsychiatric research [33,34]. SH-SY5Y cells are widely used either as undifferentiated cells or as cells differentiated into a neuron-like lineage. There are receptors for dopamine, GABA, acetylcholine, and glutamate on the surface of SH-SY5Y cells [35]. For example, the mechanisms of action of olanzapine and haloperidol on the serum withdrawal apoptosis of SH-SY5Y cells have been investigated by N.R. Kim [36]. Accordingly, in our experiment, we incubated SH-SY5Y cells with immunoglobulins G (from patients or healthy individuals) possessing significantly different oxidoreductase activities. Our results uncovered the effects having different directions depending on the levels of catalase and the SOD activities of the IgGs.
During the 24 h of incubation in a culture plate with SH-SY5Y cells, abzymes having high SOD activity could create a sufficient pool of hydrogen peroxide not completely neutralized by the low catalase activity. At micromolar concentrations, hydrogen peroxide, along with other ROS, triggers oxidative damage to proteins, nucleic acids, and lipids, thus leading to the activation of proteolytic enzymes and the disruption of the membrane structure, inevitably causing cell death [37]. We can theorize that it is the accumulation of hydrogen peroxide in the SH-SY5Y cell culture medium that can explain the observed cytotoxic effect. After a prolonged 24 h incubation of the cell line with serum immunoglobulins G from the patients in the acute phase of schizophrenia, a significant cytotoxic effect was documented. The number of dead SH-SY5Y cells when the samples of the patients’ antibodies were added to the culture medium statistically significantly exceeded this parameter in the group of healthy individuals and in the control group, consisting of cultured cells without the addition of antibodies. This finding was confirmed by the significant positive correlation between the average magnitude of the patients’ IgG SOD activity and the percentage of dead SH-SY5Y cells (r = 0.439).
Furthermore, as already stated above, it is possible that the oxidoreductase activities of class G immunoglobulins are activated by the mechanism of substrate induction, as in classic enzymes [23,24]. This notion is confirmed in the current work. Under our conditions of induced oxidative stress, the cytotoxic effect on the SH-SY5Y cell line was much more pronounced for IgG from the patients with schizophrenia (as compared to the healthy controls), once again corroborating the major role of ROS in the regulation of cell death. The clinical relevance of this topic is constantly supported by published articles [38].
In addition, in our experiments, a very interesting phenomenon was revealed. Under the induced oxidative stress, a statistically significant cytoprotective effect of IgG from the healthy individuals on the SH-SY5Y cells was registered. Currently, this phenomenon is difficult to explain. A possible reason is that, possibly, the high catalase activity of the IgG from the healthy individuals eliminates the excess hydrogen peroxide from the culture medium, which is clearly the cause of the cytotoxic effects. We believe that a small amount of hydrogen peroxide is formed spontaneously (without the induction) in 24 h even in the DMEM alone. This supposition needs further experiments to be confirmed. Be that as it may, lately, research articles on protective properties of abzymes have begun to appear. In a 2020 paper, some authors reported the first identified antibodies with sialidase activity. These antibodies are, for example, desialyze glycoproteins, gangliosides, and red blood cells. Desialylation of dying cells may facilitate the clearance of apoptotic cells [39].
Our work has several limitations. In this project, we used polyclonal antibodies (IgG) representing a mixture of immunoglobulins with different catalytic activities in one sample. Separating natural catalytic-antibody clones from antigen-binding antibodies can be challenging (due to their similar properties and structure). The current methods for separating a mixture of abzymes depending on the structure of their catalytic site make it impossible to subsequently evaluate their activity. Our findings are the first results on the cytotoxic properties of IgG having an oxidoreductase activity. Above, we tried to explain the results, and the difficult limitation will be resolved in our next study. Furthermore, detailed data on long-term antipsychotic therapy prior to hospitalization were not available, and this fact limits the interpretation of a possible confounding influence of the pharmacotherapy.

5. Conclusions

During the 24 h incubation of SH-SY5Y cells with IgG abzymes from patients with schizophrenia, a significant cytotoxic effect of these abzymes was detected, which correlated with high SOD activity. Under induced oxidative stress, the cytotoxic effect of these antibodies from the patients with schizophrenia on the SH-SY5Y cell line was more pronounced, whereas for the abzymes from the healthy individuals a cytoprotective effect on the cultured cells was observed, in combination with high catalase activity. Thus, the detected influence on cell viability depends on the catalytic properties of the abzymes.

Author Contributions

Conceptualization, S.A.I. and L.P.S.; methodology, L.P.S. and E.V.E.; software, D.A.K.; validation, L.P.S.; formal analysis, D.V.K.; investigation D.V.K., D.A.K. and E.V.E.; resources, L.P.S. and S.A.I.; data curation, L.P.S.; writing—original draft preparation, E.V.E., L.P.S., D.A.K. and D.V.K.; writing—review and editing, L.P.S.; visualization, D.V.K.; supervision, S.A.I.; project administration, S.A.I.; funding acquisition, S.A.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the State Assignment on the subject of research “Biopsychosocial mechanisms of pathogenesis and clinical polymorphism, adaptive potential and predictors of the effectiveness of therapy in patients with mental and behavioral disorders in the Siberian region”, registration number 122020200054-8.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Local Bioethics Committee of the Mental Health Research Institute Tomsk National Research Medical Center, Tomsk, Russian Federation (protocol no. 157/1.2022).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We thank the staff of the Research School of Chemistry and Applied Biomedical Sciences of Tomsk Polytechnic University for providing the SHSY5Y cell culture. The authors thank Nikolai A. Shevchuk for the proofreading and comments.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Nevinsky, G.A.; Buneva, V.N. Natural catalytic antibodies–abzymes. In Catalytic Antibodies; Keinan, E., Ed.; WILEY-VCH Verlag GmbH & Co.: Weinheim, Germany, 2005; pp. 505–569. [Google Scholar] [CrossRef]
  2. Shuster, A.M.; Gololobov, G.V.; Kvashuk, O.A.; Bogomolova, A.E.; Smirnov, I.V.; Gabibov, A.G. DNA hydrolyzing autoantibodies. Science 1992, 256, 665–667. [Google Scholar] [CrossRef]
  3. Nevinsky, G.A.; Buneva, V.N. Natural Catalytic Antibodies in Norm, Autoimmune, Viral, and bacterial Diseases. Sci. World J. 2010, 10, 1203–1233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Nevinsky, G.A.; Buneva, V.N. Autoantibodies and Natural Catalytic Antibodies in Health, Multiple Sclerosis, and Some Other Diseases. Adv. Neuroimmune Biol. 2012, 3, 157–182. [Google Scholar] [CrossRef]
  5. Ermakov, E.A.; Mednova, I.A.; Boiko, A.S.; Buneva, V.N.; Ivanova, S.A. Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review. Int. J. Mol. Sci. 2023, 24, 2215. [Google Scholar] [CrossRef] [PubMed]
  6. Boerrigter, D.; Weickert, T.W.; Lenroot, R.; O’Donnell, M.; Galletly, C.; Liu, D.; Burgess, M.; Cadiz, R.; Jacomb, I.; Catts, V.S.; et al. Using Blood Cytokine Measures to Define High Inflammatory Biotype of Schizophrenia and Schizoaffective Disorder. J. Neuroinflamm. 2017, 14, 188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Momtazmanesh, S.; Zare-Shahabadi, A.; Rezaei, N. Cytokine Alterations in Schizophrenia: An Updated Review. Front. Psychiatry 2019, 10, 892. [Google Scholar] [CrossRef] [Green Version]
  8. Huang, D.; Liu, S. Oxidative stress and schizophrenia. J. Psychiatry Brain Sci. 2017, 2, 4. [Google Scholar] [CrossRef] [Green Version]
  9. Ivanova, S.A.; Smirnova, L.P.; Shchigoreva, Y.G.; Boiko, A.S.; Semke, A.V.; Uzbekov, M.G.; Bokhan, N.A. Glucose-6-phosphate dehydrogenase and catalase activities in erythrocytes of schizophrenic patients under pharmacotherapy with traditional antipsychotics. Neurochem. J. 2014, 8, 66–70. [Google Scholar] [CrossRef]
  10. Ivanova, S.A.; Smirnova, L.P.; Shchigoreva, Y.G.; Semke, A.V.; Bokhan, N.A. Serum glutathione in patients with schizophrenia in dynamics of antipsychotic therapy. Bull. Exp. Biol. Med. 2015, 160, 283–285. [Google Scholar] [CrossRef]
  11. Shukla, V.; Mishra, S.K.; Pant, H.C. Oxidative stress in neurodegeneration. Adv. Pharmacol. Sci. 2011, 2011, 572634. [Google Scholar] [CrossRef] [Green Version]
  12. Ermakov, E.A.; Dmitrieva, E.M.; Parshukova, D.A.; Kazantseva, D.V.; Vasilieva, A.R.; Smirnova, L.P. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives. Oxidative Med. Cell. Longev. 2021, 2021, 8881770. [Google Scholar] [CrossRef] [PubMed]
  13. Smirnova, L.P.; Yarnykh, V.L.; Parshukova, D.A.; Kornetova, E.G.; Semke, A.V.; Usova, A.V.; Pishchelko, A.O.; Khodanovich, M.Y.; Ivanova, S.A. Global hypomyelination of the brain white and gray matter in schizophrenia: Quantitative imaging using macromolecular proton fraction. Transl. Psychiatry 2021, 11, 365. [Google Scholar] [CrossRef] [PubMed]
  14. Brennan, A.M.; Suh, S.W.; Won, S.J.; Narasimhan, P.; Kauppinen, T.M.; Lee, H.; Swanson, R.A. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 2009, 12, 857–863. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Zhang, M.; Zhao, Z.; He, L.; Wan, C. A meta–analysis of oxidative stress markers in schizophrenia. Sci. China Life Sci. 2010, 53, 112–124. [Google Scholar] [CrossRef]
  16. Chowdari, K.V.; Bamne, M.N.; Nimgaonkar, V.L. Genetic association studies of antioxidant pathway genes and schizophrenia. Antioxid. Redox Signal. 2011, 15, 2037–2045. [Google Scholar] [CrossRef] [Green Version]
  17. Ermakov, E.A.; Smirnova, L.P.; Parkhomenko, T.A.; Dmitrenok, P.S.; Krotenko, N.M.; Fattakhov, N.S.; Bokhan, N.A.; Semke, A.V.; Ivanova, S.A.; Buneva, V.N.; et al. DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia. Open Biol. 2015, 5, 150064. [Google Scholar] [CrossRef] [Green Version]
  18. Ermakov, E.A.; Ivanova, S.A.; Buneva, V.N.; Nevinsky, G.A. Hydrolysi s by catalytic IgGs of microRNA specific for patients with schizophrenia. IUBMB Life 2018, 70, 153–164. [Google Scholar] [CrossRef] [Green Version]
  19. Ermakov, E.A.; Parshukova, D.A.; Nevinsky, G.A.; Buneva, V.N. Natural Catalytic IgGs Hydrolyzing Histones in Schizophrenia: Are They the Link between Humoral Immunity and Inflammation? Int. J. Mol. Sci. 2020, 21, 7238. [Google Scholar] [CrossRef]
  20. Parshukova, D.A.; Smirnova, L.P.; Kornetova, E.G.; Semke, A.V.; Buneva, V.N.; Ivanova, S.A. IgG-Dependent hydrolysis of myelin basic protein of patients with different courses of schizophrenia. J. Immunol. Res. 2020, 2020, 8986521. [Google Scholar] [CrossRef]
  21. Ermakov, E.A.; Smirnova, L.P.; Bokhan, N.A.; Semke, A.V.; Ivanova, S.A.; Buneva, V.N.; Nevinsky, G.A. Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia. PLoS ONE 2017, 12, e0183867. [Google Scholar] [CrossRef] [Green Version]
  22. Mednova, I.A.; Smirnova, L.P.; Vasilieva, A.R.; Kazantseva, D.V.; Epimakhova, E.V.; Krotenko, N.M.; Semke, A.V.; Ivanova, S.A. Immunoglobulins G of Patients with Schizophrenia Protects from Superoxide: Pilot Results. J. Pers. Med. 2022, 12, 1449. [Google Scholar] [CrossRef] [PubMed]
  23. Smirnova, L.P.; Mednova, I.A.; Krotenko, N.M.; Alifirova, V.M.; Ivanova, S.A. IgG-Dependent Dismutation of Superoxide in Patients with Different Types of Multiple Sclerosis and Healthy Subjects. Oxidative Med. Cell. Longev. 2020, 2020, 8171020. [Google Scholar] [CrossRef] [PubMed]
  24. Tolmacheva, A.S.; Buneva, V.N.; Nevinsky, G.A. Substrate specificity of IgGs with peroxidase and oxidoreductase activities from sera of patients with systemic lupus erythematosus and multiple sclerosis. J. Mol. Recognit. 2019, 32, e2807. [Google Scholar] [CrossRef] [PubMed]
  25. Kozyr, A.V.; Sashchenko, L.P.; Kolesnikov, A.V.; Zelenova, N.A.; Khaidukov, S.V.; Ignatova, A.N.; Bobik, T.V.; Gabibov, A.G.; Alekberova, Z.S.; Suchkov, S.V.; et al. Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol. Lett. 2002, 80, 41–47. [Google Scholar] [CrossRef] [PubMed]
  26. Aebi, H. Catalase in vitro. Methods Enzymol. 1984, 105, 121–126. [Google Scholar] [CrossRef] [PubMed]
  27. Epimakhova, E.V.; Smirnova, L.P.; Kazantseva, D.V.; Parshukova, D.A.; Krotenko, N.M.; Vasilyeva, A.R.; Ivanova, S.A.; Semke, A.V. Evaluation of the cytotoxic effects of IgG isolated from the blood serum of schizophrenic patients. Sib. Her. Psychiatry Addict. Psychiatry 2021, 4, 5–13. [Google Scholar] [CrossRef]
  28. Smirnova, L.P.; Kondakova, I.V.; Rogozin, E.A. Antioxidant enzyme activities in the cells of solid and ascitic Ehrlich carcinomas. Exp. Oncol. 2003, 25, 60–63. [Google Scholar]
  29. De Witte, L.; Tomasik, J.; Schwarz, E.; Guest, P.C.; Rahmoune, H.; Kahn, R.S.; Bahn, S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr. Res. 2014, 154, 23–29. [Google Scholar] [CrossRef] [Green Version]
  30. Müller, N.; Schwarz, M.J. Immune system and schizophrenia. Cur. Immunol. Rev. 2010, 6, 213–220. [Google Scholar] [CrossRef]
  31. Bošković, M.; Grabnar, I.; Terzič, T.; Plesničar, B.K.; Vovk, T. Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate. Psychiatry Res. 2013, 210, 761–768. [Google Scholar] [CrossRef]
  32. Yao, J.K.; Keshavan, M.S. Antioxidants, redox signaling, and pathophysiology in schizophrenia: An integrative view. Antioxid. Redox Signal. 2011, 15, 2011–2035. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Bray, N.J.; Kapur, S.; Price, J. Investigating Schizophrenia in a “Dish”: Opportunities, potential, and limitations. World Psychiatry 2012, 11, 153–155. [Google Scholar] [CrossRef] [PubMed]
  34. Giriş, M.; Bireller, S.; Küçükali, C.; Hanağasi, H.; Değirmencioğlu, S.; Tüzün, E. Impact of Neuro-Behçet Disease Immunoglobulin G on Neuronal Apoptosis. Arch. Neuropsychiatry 2017, 54, 67–71. [Google Scholar] [CrossRef]
  35. Abashkin, D.A.; Kurishev, A.O.; Karpov, D.S.; Golimbet, V.E. Cellular models in the study of schizophrenia. Int. J. Mol. Sci. 2021, 22, 8518. [Google Scholar] [CrossRef] [PubMed]
  36. Kim, N.R.; Park, S.W.; Lee, J.G.; Kim, Y.H. Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32, 633–642. [Google Scholar] [CrossRef] [PubMed]
  37. Murphy, M.P.; Holmgren, A.; Larsson, N.-G.; Halliwell, B.; Chang, C.J.; Kalyanaraman, B.; Rhee, S.G.; Thornalley, P.J.; Partridge, L.; Gems, D.; et al. Unraveling the Biological Roles of Reactive Oxygen Species. Cell Metab. 2011, 13, 361–366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Checa, J.; Aran, J.M. Reactive oxygen species: Drivers of physiological and pathological processes. J. Inflamm. Res. 2020, 13, 1057–1073. [Google Scholar] [CrossRef]
  39. Sharapova, T.N.; Romanova, E.A.; Soshnikova, N.V.; Belogurov, A.A.; Lomakin, Y.A.; Sashchenko, L.P.; Yashin, D.V. Autoantibodies from SLE patients induce programmed cell death in murine fibroblast cells through interaction with TNFR1 receptor. Sci. Rep. 2020, 10, 11144. [Google Scholar] [CrossRef]
Cimb 45 00206 g001 550
Figure 1. Analysis of homogeneity of IgG samples after SDS-PAGE in a 4–18% gradient gel and Coomassie G250 staining. Lanes 1–5: IgGs from different schizophrenia patients; M: protein molecular-weight markers.
Figure 1. Analysis of homogeneity of IgG samples after SDS-PAGE in a 4–18% gradient gel and Coomassie G250 staining. Lanes 1–5: IgGs from different schizophrenia patients; M: protein molecular-weight markers.
Cimb 45 00206 g001
Cimb 45 00206 g002 550
Figure 2. (A). The protein elution profile of gel filtration of IgGs under pH shock conditions (solid curve) and the change in relative activity (RA) of the IgG during the degradation of H2O2 in the presence or absence of IgG having catalase activity in the obtained fractions (dashed curve). (B). The protein elution profile of gel filtration of IgGs under pH shock conditions (solid curve) and the change in optical density of the solution per minute (∆E/min) in the presence or absence of IgGs having SOD activity in the obtained fractions (dashed curve).
Figure 2. (A). The protein elution profile of gel filtration of IgGs under pH shock conditions (solid curve) and the change in relative activity (RA) of the IgG during the degradation of H2O2 in the presence or absence of IgG having catalase activity in the obtained fractions (dashed curve). (B). The protein elution profile of gel filtration of IgGs under pH shock conditions (solid curve) and the change in optical density of the solution per minute (∆E/min) in the presence or absence of IgGs having SOD activity in the obtained fractions (dashed curve).
Cimb 45 00206 g002
Cimb 45 00206 g003 550
Figure 3. Registration of cells on the CX7 platform. (A): SH-SY5Y cells after 24 h of incubation with IgG from schizophrenic patients; (B): SH-SY5Y cells after 24 h of incubation under conditions of induced oxidative stress (TBH) along with IgG from schizophrenic patients. (a) Cells stained with the Hoechst fluorescent dye; (b) cells stained with fluorescent dye propidium iodide; (c) cells stained with Hoechst + propidium iodide. Scale bars: 100 μm.
Figure 3. Registration of cells on the CX7 platform. (A): SH-SY5Y cells after 24 h of incubation with IgG from schizophrenic patients; (B): SH-SY5Y cells after 24 h of incubation under conditions of induced oxidative stress (TBH) along with IgG from schizophrenic patients. (a) Cells stained with the Hoechst fluorescent dye; (b) cells stained with fluorescent dye propidium iodide; (c) cells stained with Hoechst + propidium iodide. Scale bars: 100 μm.
Cimb 45 00206 g003
Cimb 45 00206 g004 550
Figure 4. Percentages of dead SH-SY5Y cells after 24 h of incubation with IgG from schizophrenic patients or from healthy individuals or without antibodies (the culture medium alone).
Figure 4. Percentages of dead SH-SY5Y cells after 24 h of incubation with IgG from schizophrenic patients or from healthy individuals or without antibodies (the culture medium alone).
Cimb 45 00206 g004
Cimb 45 00206 g005 550
Figure 5. Percentages of dead SH-SY5Y cells after 24 h of induced oxidative stress (TBH) combined with incubation with IgG from schizophrenia patients or from healthy individuals or without antibodies (the culture medium alone).
Figure 5. Percentages of dead SH-SY5Y cells after 24 h of induced oxidative stress (TBH) combined with incubation with IgG from schizophrenia patients or from healthy individuals or without antibodies (the culture medium alone).
Cimb 45 00206 g005
Table
Table 1. Patients’ and healthy control subjects’ characteristics.
Table 1. Patients’ and healthy control subjects’ characteristics.
Healthy Control Subjectsn = 18
Age (years)
Median and interquartile range44.00 [35.00; 49.00]
Male/female ratio7/11
Patients with Schizophrenian = 16
Age (years)
Median and interquartile range40.50 [38.00; 45.50]
Male/female ratio11/7
Duration of disease (years)
Median and interquartile range19.00 [17.00; 22.00]
Table
Table 2. Catalase and SOD activities of IgGs from patients with acute schizophrenia and healthy controls.
Table 2. Catalase and SOD activities of IgGs from patients with acute schizophrenia and healthy controls.
Healthy ControlsPatients with Schizophreniap-Value of Difference
Catalase activity of IgGs, (mM H2O2/min/mg IgG)598.13 ± 93.38183.07 ± 10.060.02
SOD activity of IgGs (μM diformazan/min/mg of protein)182.13 ± 32.81207.01 ± 40.910.02
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Epimakhova, E.V.; Smirnova, L.P.; Kazantseva, D.V.; Kamaeva, D.A.; Ivanova, S.A. Different Directions of Effects of Polyclonal IgG Antibodies from Patients with Schizophrenia and Healthy Individuals on Cell Death In Vitro: A Pilot Study. Curr. Issues Mol. Biol. 2023, 45, 3168-3179. https://doi.org/10.3390/cimb45040206

AMA Style

Epimakhova EV, Smirnova LP, Kazantseva DV, Kamaeva DA, Ivanova SA. Different Directions of Effects of Polyclonal IgG Antibodies from Patients with Schizophrenia and Healthy Individuals on Cell Death In Vitro: A Pilot Study. Current Issues in Molecular Biology. 2023; 45(4):3168-3179. https://doi.org/10.3390/cimb45040206

Chicago/Turabian Style

Epimakhova, Elena V., Liudmila P. Smirnova, Daria V. Kazantseva, Daria A. Kamaeva, and Svetlana A. Ivanova. 2023. "Different Directions of Effects of Polyclonal IgG Antibodies from Patients with Schizophrenia and Healthy Individuals on Cell Death In Vitro: A Pilot Study" Current Issues in Molecular Biology 45, no. 4: 3168-3179. https://doi.org/10.3390/cimb45040206

Article Metrics

Back to TopTop